| Revenue growth | Value |
|---|---|
| 3Y CAGR | +9% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +4% |
| Fund name | AUM% |
|---|---|
| 0.48 |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,667.70 -16.70 (0.36%) | 21,441.05 | 29.16 | 5.1 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,624.70 +107.30 (4.26%) | 19,134.04 | 28.22 | 5.34 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,938.00 -13.50 (0.19%) | 17,426.88 | 102.74 | 19.97 | ||
Natco PharmaNATCOPHARM | ₹841.85 +0.35 (0.04%) | 15,085.53 | 13.18 | 1.64 |